
Kevin M. Johnson
Examiner (ID: 17187)
| Most Active Art Unit | 1793 |
| Art Unit(s) | 1793, 1732 |
| Total Applications | 255 |
| Issued Applications | 85 |
| Pending Applications | 85 |
| Abandoned Applications | 85 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18443527
[patent_doc_number] => 11679078
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-06-20
[patent_title] => Ophthalmic formulations and related methods
[patent_app_type] => utility
[patent_app_number] => 17/689212
[patent_app_country] => US
[patent_app_date] => 2022-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 18967
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17689212
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/689212 | Ophthalmic formulations and related methods | Mar 7, 2022 | Issued |
Array
(
[id] => 17850632
[patent_doc_number] => 20220280673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => BIODEGRADABLE NON-WOVEN FABRIC SHEET
[patent_app_type] => utility
[patent_app_number] => 17/653172
[patent_app_country] => US
[patent_app_date] => 2022-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8315
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17653172
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/653172 | BIODEGRADABLE NON-WOVEN FABRIC SHEET | Mar 1, 2022 | Abandoned |
Array
(
[id] => 17836278
[patent_doc_number] => 20220273583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => METHOD FOR DELIVERING AN AGENT TO POSTERIOR SEGMENT OF AN EYE AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/681121
[patent_app_country] => US
[patent_app_date] => 2022-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12033
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17681121
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/681121 | Method for delivering an agent to posterior segment of an eye and uses thereof | Feb 24, 2022 | Issued |
Array
(
[id] => 17702700
[patent_doc_number] => 20220202706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => SUSTAINED RELEASE BIODEGRADABLE INTRACANALICULAR INSERTS COMPRISING A HYDROGEL AND CYCLOSPORINE
[patent_app_type] => utility
[patent_app_number] => 17/681238
[patent_app_country] => US
[patent_app_date] => 2022-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37915
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17681238
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/681238 | Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine | Feb 24, 2022 | Issued |
Array
(
[id] => 19195340
[patent_doc_number] => 11992559
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-28
[patent_title] => Microsphere formulations comprising lurasidone and methods for making and using the same
[patent_app_type] => utility
[patent_app_number] => 17/679385
[patent_app_country] => US
[patent_app_date] => 2022-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 5349
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17679385
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/679385 | Microsphere formulations comprising lurasidone and methods for making and using the same | Feb 23, 2022 | Issued |
Array
(
[id] => 17640478
[patent_doc_number] => 20220168216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => TOPICAL COMPOSITIONS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/675654
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27717
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17675654
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/675654 | TOPICAL COMPOSITIONS AND METHODS OF USING THE SAME | Feb 17, 2022 | Pending |
Array
(
[id] => 18550003
[patent_doc_number] => 20230248001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => STORAGE STABLE SOLUTION COMPRISING HYPOCHLOROUS ACID AND/OR HYPOCHLORITE
[patent_app_type] => utility
[patent_app_number] => 17/668356
[patent_app_country] => US
[patent_app_date] => 2022-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6069
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17668356
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/668356 | STORAGE STABLE SOLUTION COMPRISING HYPOCHLOROUS ACID AND/OR HYPOCHLORITE | Feb 8, 2022 | Abandoned |
Array
(
[id] => 17576870
[patent_doc_number] => 20220133725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => PULSE DOSING REGIMEN AND METHODS OF TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/572491
[patent_app_country] => US
[patent_app_date] => 2022-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12651
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17572491
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/572491 | Pulse dosing regimen and methods of treatment | Jan 9, 2022 | Issued |
Array
(
[id] => 17561581
[patent_doc_number] => 20220125730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => METHOD OF MANUFACTURING AN ORALLY DISINTIGRATING TABLET
[patent_app_type] => utility
[patent_app_number] => 17/570548
[patent_app_country] => US
[patent_app_date] => 2022-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12208
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17570548
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/570548 | METHOD OF MANUFACTURING AN ORALLY DISINTIGRATING TABLET | Jan 6, 2022 | Abandoned |
Array
(
[id] => 17532505
[patent_doc_number] => 20220111114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => EMBOLIC MICROSPHERES
[patent_app_type] => utility
[patent_app_number] => 17/557175
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5694
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17557175
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/557175 | EMBOLIC MICROSPHERES | Dec 20, 2021 | Pending |
Array
(
[id] => 19554710
[patent_doc_number] => 20240366502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => ORODISPERSIBLE POWDER COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/255675
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9134
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18255675
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/255675 | Orodispersible powder composition | Dec 20, 2021 | Issued |
Array
(
[id] => 17685804
[patent_doc_number] => 20220193096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => INHIBITORS OF NCCA-ATP CHANNELS FOR THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/645239
[patent_app_country] => US
[patent_app_date] => 2021-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57429
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17645239
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/645239 | INHIBITORS OF NCCA-ATP CHANNELS FOR THERAPY | Dec 19, 2021 | Abandoned |
Array
(
[id] => 18970430
[patent_doc_number] => 20240050522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => COMPOSITIONS AND METHODS FOR PREVENTING, ATTENUATING, AND TREATING MEDICAL CONDITIONS WITH sHDL NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 18/266542
[patent_app_country] => US
[patent_app_date] => 2021-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29315
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -81
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18266542
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/266542 | COMPOSITIONS AND METHODS FOR PREVENTING, ATTENUATING, AND TREATING MEDICAL CONDITIONS WITH sHDL NANOPARTICLES | Dec 9, 2021 | Pending |
Array
(
[id] => 18901260
[patent_doc_number] => 20240016745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => TIMED-ELUTION MASKING PARTICLES AND ORAL PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/265042
[patent_app_country] => US
[patent_app_date] => 2021-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15435
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18265042
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/265042 | TIMED-ELUTION MASKING PARTICLES AND ORAL PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | Dec 3, 2021 | Pending |
Array
(
[id] => 18815852
[patent_doc_number] => 20230390191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => SELF-REGULATING BIOADHESIVES FOR WET SUBSTRATES
[patent_app_type] => utility
[patent_app_number] => 18/254756
[patent_app_country] => US
[patent_app_date] => 2021-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21987
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18254756
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/254756 | SELF-REGULATING BIOADHESIVES FOR WET SUBSTRATES | Nov 29, 2021 | Pending |
Array
(
[id] => 17748077
[patent_doc_number] => 20220226280
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => COMPOSITIONS AND METHODS FOR INCREASED GLUCOSE UPTAKE AND FAT METABOLISM
[patent_app_type] => utility
[patent_app_number] => 17/533715
[patent_app_country] => US
[patent_app_date] => 2021-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6944
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17533715
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/533715 | COMPOSITIONS AND METHODS FOR INCREASED GLUCOSE UPTAKE AND FAT METABOLISM | Nov 22, 2021 | Abandoned |
Array
(
[id] => 19065616
[patent_doc_number] => 20240100042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-28
[patent_title] => BRUCINE GEL PLASTER AND PREPARATION METHOD AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/253878
[patent_app_country] => US
[patent_app_date] => 2021-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5920
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18253878
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/253878 | BRUCINE GEL PLASTER AND PREPARATION METHOD AND USE THEREOF | Nov 18, 2021 | Pending |
Array
(
[id] => 18860061
[patent_doc_number] => 20230414495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => PUNCTAL PLUGS CONTAINING MICELLE-ENCAPSULATED OPHTHALMIC PHARMACEUTICALS AND METHODS FOR MAKING THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/035816
[patent_app_country] => US
[patent_app_date] => 2021-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5263
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18035816
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/035816 | PUNCTAL PLUGS CONTAINING MICELLE-ENCAPSULATED OPHTHALMIC PHARMACEUTICALS AND METHODS FOR MAKING THEREOF | Nov 7, 2021 | Abandoned |
Array
(
[id] => 17412681
[patent_doc_number] => 20220047585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => PREVENTING OR TREATING AGENT FOR GLAUCOMA
[patent_app_type] => utility
[patent_app_number] => 17/516145
[patent_app_country] => US
[patent_app_date] => 2021-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2937
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17516145
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/516145 | PREVENTING OR TREATING AGENT FOR GLAUCOMA | Oct 31, 2021 | Abandoned |
Array
(
[id] => 17953502
[patent_doc_number] => 11479593
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-25
[patent_title] => Compositions, formulations and interleukin production and purification
[patent_app_type] => utility
[patent_app_number] => 17/512315
[patent_app_country] => US
[patent_app_date] => 2021-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 182
[patent_figures_cnt] => 293
[patent_no_of_words] => 82778
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17512315
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/512315 | Compositions, formulations and interleukin production and purification | Oct 26, 2021 | Issued |